Product image of Nootropil (Piracetam) supplied by GNH India

Nootropil

Active Ingredient:
Piracetam
Origin:
EU

Nootropil (Piracetam)

Piracetam, the active ingredient in Nootropil, is a racetam (nootropic) presented as an oral tablet for oral use. It is used to support cognitive function and is prescribed for individuals with cognitive impairment, such as age‑related decline or post‑stroke deficits.

GNH India supplies Nootropil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. All products are manufactured under GMP conditions and undergo rigorous testing before distribution.

Manufacturer / TM Owner

Mercury Pharmaceuticals Ltd.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Piracetam is a racetam nootropic that acts on cognitive pathways and neurological disorders.

  • Cognitive impairment: improves memory, attention and overall cognitive performance in age‑related decline or post‑stroke patients.
  • Myoclonus: reduces frequency and severity of involuntary muscle jerks associated with cortical myoclonus.
  • Vertigo: alleviates balance disturbances and dizziness in patients with vestibular disorders.

How It Works

  • Piracetam modulates neuronal membrane fluidity and influences ion channel activity, enhancing the function of neurotransmitter systems such as acetylcholine and glutamate. It improves cerebral blood flow and oxygen utilization, supporting neuroplasticity and synaptic transmission. Additionally, piracetam may increase the activity of ATP‑dependent enzymes, contributing to cellular energy metabolism.

Side Effects

Piracetam is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects

  • Headache: mild to moderate intensity, often transient.
  • Insomnia: difficulty initiating or maintaining sleep.
  • Nausea: occasional gastrointestinal upset.
  • Dizziness: sensation of light‑headedness.
  • Anxiety: increased nervousness or restlessness.
  • Gastrointestinal discomfort: abdominal pain or dyspepsia.

Serious or Rare Side Effects

  • Allergic reactions: rash, pruritus or angioedema.
  • Hematologic disorders: thrombocytopenia or leukopenia.
  • Severe skin reactions: Stevens‑Johnson syndrome.
  • Seizures: rare occurrence in predisposed individuals.
  • Depression or mood changes: significant affective disturbances.
  • Liver enzyme elevation: abnormal hepatic function tests.

Precautions & Warnings

When prescribing piracetam, clinicians should consider several precautionary measures to ensure patient safety.

  • Renal function: adjust use in patients with severe renal impairment.
  • Hepatic function: monitor liver enzymes in long‑term therapy.
  • Elderly patients: start with lower doses due to increased sensitivity.
  • Pregnancy: use only if potential benefit justifies potential risk, as data are limited.
  • Concomitant CNS depressants: caution as additive sedation may occur.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Avoid Interactions

Piracetam may interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): increased bleeding risk.
  • Antiepileptic drugs (e.g., carbamazepine): reduced piracetam plasma levels.
  • Central nervous system depressants (e.g., alcohol, benzodiazepines): enhanced sedation.

Moderate Interactions (Monitor Closely)

  • Antihistamines: possible increase in drowsiness.
  • Other nootropics (e.g., aniracetam): additive cognitive effects.
  • Diuretics: may alter electrolyte balance, requiring monitoring.

Frequently Asked Questions

Nootropil contains piracetam, a racetam‑class nootropic that is primarily prescribed to support cognitive function in individuals with cognitive impairment, such as age‑related decline, post‑stroke deficits, or other conditions affecting memory and attention.

Piracetam modulates neuronal membrane fluidity, influences ion channel activity, and enhances neurotransmitter systems like acetylcholine and glutamate. These actions improve cerebral blood flow, oxygen utilization, and neuroplasticity, which together may help improve cognitive processing.

The appropriate dose of Nootropil is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for piracetam during pregnancy and lactation are limited. It should only be used if the potential therapeutic benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Piracetam belongs to the racetam family of nootropics. Compared with other racetams such as aniracetam or oxiracetam, piracetam has a longer safety record and is often the first‑line choice for cognitive support, though potency and specific effects may differ among agents.

Nootropil tablets should be stored at ambient temperature, preferably below 25 °C, in their original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in damp or excessively hot environments.

Nootropil is administered orally, typically as a tablet that is swallowed with water. The exact timing (e.g., with or without food) and frequency are determined by the prescribing clinician based on the individual treatment plan.

Serious but rare risks include allergic reactions such as rash or angioedema, hematologic abnormalities like thrombocytopenia, severe skin reactions (e.g., Stevens‑Johnson syndrome), seizures in predisposed individuals, and significant mood changes such as depression.

Nootropil should be avoided in patients with known hypersensitivity to piracetam or any excipients, in those with severe renal impairment without dose adjustment, and in pregnant or breastfeeding women unless the prescriber determines that the benefits outweigh the risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Piracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT